(Q48864958)

16 February 2018

title

Disease burden of post-infectious irritable bowel syndrome in The Netherlands (English)

1 reference

16 February 2018

main subject

Netherlands

0 references

irritable bowel syndrome

1 reference

J A Haagsma

1

1 reference

16 February 2018

P D Siersema

series ordinal

2

1 reference

16 February 2018

N J De Wit

series ordinal

3

1 reference

16 February 2018

A H Havelaar

series ordinal

4

1 reference

16 February 2018

publication date

12 March 2010

1 reference

16 February 2018

Epidemiology and Infection

published in

1 reference

16 February 2018

volume

138

1 reference

16 February 2018

issue

11

1 reference

16 February 2018

page(s)

1650-1656

1 reference

16 February 2018

https://api.crossref.org/works/10.1017%2FS0950268810000531

1 reference

Quality of life in patients with different types of functional constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Role of infection in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Postinfectious irritable bowel syndrome--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Randomized patients in IBS research had different disease characteristics compared to eligible and recruited patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Health burden in the Netherlands due to infection with thermophilic Campylobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Feasibility and reliability of the annual profile method for deriving QALYs for short-term health conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Systematic review: prevention of travellers' diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Sensor, a Population-based Cohort Study on Gastroenteritis in the Netherlands: Incidence and Etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

7 January 2021

Irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

7 January 2021

Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

7 January 2021

A comparison of the EQ-5D and SF-6D across seven patient groups

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

7 January 2021

Postinfectious irritable bowel syndrome may occur after non-gastrointestinal and intestinal infection

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

7 January 2021

Postinfectious irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

7 January 2021

Post-infectious irritable bowel syndrome in patients with Shigella infection

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810000531

7 January 2021

10.1017/S0950268810000531

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018